Should Continuous Subcutaneous Insulin Infusion (CSII) Pumps Be Used During the Perioperative Period? Development of a Clinical Decision Algorithm.

According to the Centers for Disease Control and Prevention, there are 30.3 million Americans with diabetes mellitus (DM). It is estimated that more than 400,000 individuals with DM are using continuous subcutaneous insulin infusion (CSII) pumps as a method to maintain blood glucose control.